95 related articles for article (PubMed ID: 8457038)
1. Early and late nasal symptom response to allergen challenge. The effect of pretreatment with a glucocorticosteroid spray.
Grønborg H; Bisgaard H; Rømeling F; Mygind N
Allergy; 1993 Feb; 48(2):87-93. PubMed ID: 8457038
[TBL] [Abstract][Full Text] [Related]
2. Budesonide and nasal allergen challenge testing in man.
Pipkorn U
Allergy; 1982 Feb; 37(2):129-34. PubMed ID: 7137521
[TBL] [Abstract][Full Text] [Related]
3. Effect of terfenadine and budesonide on nasal symptoms, olfaction, and nasal airway patency following allergen challenge.
Hilberg O
Allergy; 1995 Aug; 50(8):683-8. PubMed ID: 7503405
[TBL] [Abstract][Full Text] [Related]
4. Establishing a model of seasonal allergic rhinitis and demonstrating dose-response to a topical glucocorticosteroid.
Ahlström-Emanuelsson C; Persson CG; Svensson C; Andersson M; Hosszu Z; Akerlund A; Greiff L
Ann Allergy Asthma Immunol; 2002 Aug; 89(2):159-65. PubMed ID: 12197572
[TBL] [Abstract][Full Text] [Related]
5. Effect of a single dose of a topical glucocorticoid and a cyclo-oxygenase inhibitor on allergen-induced changes in nasal reactivity.
Klementsson H; Lindqvist N; Andersson M; Pipkorn U
Allergy; 1990 Nov; 45(8):604-11. PubMed ID: 2126915
[TBL] [Abstract][Full Text] [Related]
6. Budesonide and nasal histamine challenge.
Pipkorn U
Allergy; 1982 Jul; 37(5):359-63. PubMed ID: 7125153
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid-induced attenuation of mucosal exudation of fibrinogen and bradykinins in seasonal allergic rhinitis.
Svensson C; Klementsson H; Andersson M; Pipkorn U; Alkner U; Persson CG
Allergy; 1994 Mar; 49(3):177-83. PubMed ID: 8198250
[TBL] [Abstract][Full Text] [Related]
8. Topical glucocorticosteroids and allergen-induced increase in nasal reactivity: relationship between treatment time and inhibitory effect.
Andersson M; Andersson P; Pipkorn U
J Allergy Clin Immunol; 1988 Dec; 82(6):1019-26. PubMed ID: 3060511
[TBL] [Abstract][Full Text] [Related]
9. Eosinophils and eosinophil cationic protein in nasal lavages in allergen-induced hyperresponsiveness: effects of topical glucocorticosteroid treatment.
Andersson M; Andersson P; Venge P; Pipkorn U
Allergy; 1989 Jul; 44(5):342-8. PubMed ID: 2669553
[TBL] [Abstract][Full Text] [Related]
10. A double-blind comparison of nasal budesonide and oral astemizole for the treatment of perennial rhinitis.
Bunnag C; Jareoncharsri P; Wong EC
Allergy; 1992 Aug; 47(4 Pt 1):313-7. PubMed ID: 1443451
[TBL] [Abstract][Full Text] [Related]
11. The effect of budesonide on the immediate reaction to allergen challenge - a rhinomanometric study.
Pipkorn U
Eur J Respir Dis Suppl; 1982; 122():185-91. PubMed ID: 6958484
[TBL] [Abstract][Full Text] [Related]
12. The effect of budesonide on nasal allergen challenge in patients with seasonal rhinitis and on nasal peak flow in healthy volunteers.
Munch EP; Weeke B; Johansson SA
Eur J Respir Dis Suppl; 1982; 122():176-84. PubMed ID: 6958483
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of dexchlorpheniramine maleate sustained release tablets and budesonide nasal spray in seasonal allergic rhinitis.
Munch EP; Søborg M; Nørreslet TT; Mygind N
Allergy; 1983 Oct; 38(7):517-24. PubMed ID: 6139040
[TBL] [Abstract][Full Text] [Related]
14. Allergen-induced specific and non-specific nasal reactions. Reciprocal relationship and inhibition by topical glucocorticosteroids.
Andersson M; Andersson P; Pipkorn U
Acta Otolaryngol; 1989; 107(3-4):270-7. PubMed ID: 2648750
[TBL] [Abstract][Full Text] [Related]
15. Nasal inhalation of the glucocorticoid budesonide from a spacer for the treatment of patients with pollen rhinitis and asthma.
Pedersen B; Dahl R; Lindqvist N; Mygind N
Allergy; 1990 Aug; 45(6):451-6. PubMed ID: 2244675
[TBL] [Abstract][Full Text] [Related]
16. Immediate effect of topical budesonide on allergen challenge-induced nasal mucosal fluid levels of granulocyte-macrophage colony-stimulating factor and interleukin-5.
Linden M; Svensson C; Andersson E; Andersson M; Greiff L; Persson CG
Am J Respir Crit Care Med; 2000 Nov; 162(5):1705-8. PubMed ID: 11069800
[TBL] [Abstract][Full Text] [Related]
17. Budesonide powder administration for the treatment of grass-pollen-induced allergic rhinitis.
Pedersen B; Larsen BB; Dahl R; Hedbys L; Mygind N
Allergy; 1994 Dec; 49(10):855-60. PubMed ID: 7709995
[TBL] [Abstract][Full Text] [Related]
18. The treatment of perennial rhinitis with a new, non-halogenated, topical, aerosol packed, steroid, Budesonide.
Balle VH; Pedersen U; Engby B
Acta Otolaryngol; 1982; 94(1-2):169-73. PubMed ID: 7124383
[TBL] [Abstract][Full Text] [Related]
19. Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis.
Masuyama K; Jacobson MR; Rak S; Meng Q; Sudderick RM; Kay AB; Lowhagen O; Hamid Q; Durham SR
Immunology; 1994 Jun; 82(2):192-9. PubMed ID: 7927488
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent effects of budesonide aqueous nasal spray on symptoms in a daily nasal allergen challenge model.
Andersson M; Svensson C; Persson C; Akerlund A; Greiff L
Ann Allergy Asthma Immunol; 2000 Oct; 85(4):279-83. PubMed ID: 11061470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
